Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ketil Heimdal

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Bioscience Reports|April 12, 2017
<i>In vitro</i> characterization of six <i>STUB1</i> variants in spinocerebellar ataxia 16 reveals altered structural properties for the encoded CHIP proteinsYasaman Pakdaman, Monica Sanchez-Guixé, Rune Kleppe, et al.
Journal of Cancer Research and Clinical Oncology|May 16, 2009
APC mutation spectrum of Norwegian familial adenomatous polyposis families: high ratio of novel mutationsPer Arne Andresen, Ketil Heimdal, Kristin Aaberg, et al.
Orphanet Journal of Rare Diseases|October 13, 2021
The impact of demographic and clinical characteristics on the trajectories of health-related quality of life among patients with Fabry diseaseSolrun Sigurdardottir, Birgitte Bjerkely, Trond G Jenssen, et al.
Orphanet Journal of Rare Diseases|December 2, 2023
Effectiveness and safety of everolimus treatment in patients with tuberous sclerosis complex in real-world clinical practiceIne Cockerell, Jakob Christensen, Christina E Hoei-Hansen, et al.
JIMD Reports|November 12, 2021
Health-related quality of life in Norwegian adults with Fabry disease: Disease severity, pain, fatigue and psychological distressHege Kampen Pihlstrøm, Mina Susanne Weedon-Fekjær, Birgitte Leisner Bjerkely, et al.
Oncotarget|September 22, 2018
Biochemical and cellular consequences of the antithrombin p.Met1? mutation identified in a severe thrombophilic familyJosé Navarro-Fernández, María Eugenia de la Morena-Barrio, Emma Martínez-Alonso, et al.
International Journal of Cancer|September 19, 2002
Survival in prospectively ascertained familial breast cancer: analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomyPål Møller, Ake Borg, D Gareth Evans, et al.
Orphanet Journal of Rare Diseases|September 27, 2014
STUB1 mutations in autosomal recessive ataxias - evidence for mutation-specific clinical heterogeneityKetil Heimdal, Monica Sanchez-Guixé, Ingvild Aukrust, et al.
European Journal of Human Genetics : EJHG|April 24, 2018
A decision tree for the genetic diagnosis of deficiency of adenosine deaminase 2 (DADA2): a French reference centres experienceMélanie Rama, Claire Duflos, Isabelle Melki, et al.
Familial Cancer|July 18, 2009
Younger age-at-diagnosis for familial malignant testicular germ cell tumorPhuong L Mai, Bingshu E Chen, Kathy Tucker, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Bioscience Reports|April 12, 2017
<i>In vitro</i> characterization of six <i>STUB1</i> variants in spinocerebellar ataxia 16 reveals altered structural properties for the encoded CHIP proteinsYasaman Pakdaman, Monica Sanchez-Guixé, Rune Kleppe, et al.
Journal of Cancer Research and Clinical Oncology|May 16, 2009
APC mutation spectrum of Norwegian familial adenomatous polyposis families: high ratio of novel mutationsPer Arne Andresen, Ketil Heimdal, Kristin Aaberg, et al.
Orphanet Journal of Rare Diseases|October 13, 2021
The impact of demographic and clinical characteristics on the trajectories of health-related quality of life among patients with Fabry diseaseSolrun Sigurdardottir, Birgitte Bjerkely, Trond G Jenssen, et al.
Orphanet Journal of Rare Diseases|December 2, 2023
Effectiveness and safety of everolimus treatment in patients with tuberous sclerosis complex in real-world clinical practiceIne Cockerell, Jakob Christensen, Christina E Hoei-Hansen, et al.
JIMD Reports|November 12, 2021
Health-related quality of life in Norwegian adults with Fabry disease: Disease severity, pain, fatigue and psychological distressHege Kampen Pihlstrøm, Mina Susanne Weedon-Fekjær, Birgitte Leisner Bjerkely, et al.
Oncotarget|September 22, 2018
Biochemical and cellular consequences of the antithrombin p.Met1? mutation identified in a severe thrombophilic familyJosé Navarro-Fernández, María Eugenia de la Morena-Barrio, Emma Martínez-Alonso, et al.
International Journal of Cancer|September 19, 2002
Survival in prospectively ascertained familial breast cancer: analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomyPål Møller, Ake Borg, D Gareth Evans, et al.
Orphanet Journal of Rare Diseases|September 27, 2014
STUB1 mutations in autosomal recessive ataxias - evidence for mutation-specific clinical heterogeneityKetil Heimdal, Monica Sanchez-Guixé, Ingvild Aukrust, et al.
European Journal of Human Genetics : EJHG|April 24, 2018
A decision tree for the genetic diagnosis of deficiency of adenosine deaminase 2 (DADA2): a French reference centres experienceMélanie Rama, Claire Duflos, Isabelle Melki, et al.
Familial Cancer|July 18, 2009
Younger age-at-diagnosis for familial malignant testicular germ cell tumorPhuong L Mai, Bingshu E Chen, Kathy Tucker, et al.
Pageof 6